Confidential Treatment Requested by BioDelivery Sciences International, Inc. Confidential treatment requested with respect to certain portions hereof denoted with “***” ***CONFIDENTIAL TREATMENT REQUESTED*** Note: Confidential treatment requested with...Stock Purchase Agreement • April 1st, 2013 • Biodelivery Sciences International Inc • Pharmaceutical preparations • Delaware
THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”) is entered into as of March 26, 2013 (the “Effective Date”) by and between BioDelivery Sciences International, Inc., a Delaware corporation having an address at 801 Corporate Center Dr., Suite 210, Raleigh, North Carolina 27607 (“BDSI”), and Arcion Therapeutics, Inc., a Delaware corporation having an address at 2400 Boston St., Suite 330 Baltimore, Maryland 21224 (“Arcion”). Arcion and BDSI may be referred to herein individually as a “Party” or collectively, as the “Parties.”
